Aadi Bioscience (FRA:3350) Net Change in Cash : €18.29 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Aadi Bioscience Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Aadi Bioscience's Net Change in Cash for the three months ended in Mar. 2024 was €-8.38 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was €18.29 Mil.

Aadi Bioscience Net Change in Cash Historical Data

The historical data trend for Aadi Bioscience's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aadi Bioscience Net Change in Cash Chart

Aadi Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

-9.46

127.91

-103.75

21.89

Aadi Bioscience Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial										-4.65	31.49	0.60	-5.43	-8.38

Aadi Bioscience Net Change in Cash Calculation

Aadi Bioscience's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-54.711	+	76.3	+	0.299	+	0
	=	21.89

Aadi Bioscience's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -18.081 + 9.711 + -0.009 + 0

= -8.38

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €18.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aadi Bioscience Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Aadi Bioscience's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Aadi Bioscience (FRA:3350) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (FRA:3350) » Definitions » Net Change in Cash

Comparable Companies

AAGH SGMO SEER GOSS CYT NYMXF PROK PRLD ABOS MLEC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX

Traded in Other Exchanges

AADI:USA 3350:Germany

Address

17383 Sunset Boulevard, Suite A250, Pacific Palisades, CA, USA, 90272

Website

https://www.aadibio.com

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience (FRA:3350) Headlines

No Headlines